| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -11,212,938 | -8,025,660 |
| Disposals of property and equipment | 0 | 0 |
| Reductions to intellectual property | 0 | 0 |
| Net cash provided by investing activities | 0 | 0 |
| Net proceeds from issuances of common stock, pre-funded warrants, and warrants | 10,714,593 | 7,770,844 |
| Net cash provided by financing activities | 10,714,593 | 7,770,844 |
| Net decrease in cash and cash equivalents | -498,345 | -254,816 |
| Cash and cash equivalents at beginning of period | 1,601,660 | - |
| Cash and cash equivalents at end of period | 1,103,315 | - |
Genprex, Inc. (GNPX)
Genprex, Inc. (GNPX)